Alvotech Stock Performance
| ALVO Stock | USD 5.37 0.05 0.92% |
Alvotech has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.24, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Alvotech will likely underperform. Alvotech right now shows a risk of 3.97%. Please confirm Alvotech treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Alvotech will be following its price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Alvotech may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Actual Historical Performance (%)
One Day Return (0.92) | Five Day Return 3.87 | Year To Date Return 7.4 | Ten Year Return (52.01) | All Time Return (52.01) |
1 | Alvotech Announces Earnings Results | 11/14/2025 |
2 | Alvotech stock hits 52-week low at 4.69 USD By Investing.com - Investing.com UK | 12/02/2025 |
3 | Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed Offering | 12/17/2025 |
4 | ALVO Investor News If You Have Suffered Losses in Alvotech , You Are Encouraged to Contact The Rosen Law Firm About Your Rights | 12/29/2025 |
5 | Alvotech Secures Term Loan Facility of USD 100 Million | 12/31/2025 |
6 | A Look At Alvotech Valuation After New US100 Million Term Loan To Fund Biosimilar Pipeline | 01/05/2026 |
7 | Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea 2mg | 01/29/2026 |
| Begin Period Cash Flow | 11.2 M | |
| Total Cashflows From Investing Activities | -18.9 M |
Alvotech Relative Risk vs. Return Landscape
If you would invest 503.00 in Alvotech on November 2, 2025 and sell it today you would earn a total of 34.00 from holding Alvotech or generate 6.76% return on investment over 90 days. Alvotech is currently generating 0.1832% in daily expected returns and assumes 3.9694% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Alvotech, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Alvotech Target Price Odds to finish over Current Price
The tendency of Alvotech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.37 | 90 days | 5.37 | about 50.92 |
Based on a normal probability distribution, the odds of Alvotech to move above the current price in 90 days from now is about 50.92 (This Alvotech probability density function shows the probability of Alvotech Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.24 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Alvotech will likely underperform. Additionally Alvotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Alvotech Price Density |
| Price |
Predictive Modules for Alvotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alvotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alvotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Alvotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Alvotech is not an exception. The market had few large corrections towards the Alvotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Alvotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Alvotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.55 | |
β | Beta against Dow Jones | 1.24 | |
σ | Overall volatility | 0.87 | |
Ir | Information ratio | -0.09 |
Alvotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alvotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alvotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Alvotech had very high historical volatility over the last 90 days | |
| Alvotech has a very high chance of going through financial distress in the upcoming years | |
| Alvotech currently holds 1.19 B in liabilities. Alvotech has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Alvotech's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 489.68 M. Net Loss for the year was (231.86 M) with profit before overhead, payroll, taxes, and interest of 318.74 M. | |
| Alvotech currently holds about 128.44 M in cash with (236.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52. | |
| Roughly 62.0% of the company shares are held by company insiders | |
| Latest headline from globenewswire.com: Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea 2mg |
Alvotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Alvotech Stock often depends not only on the future outlook of the current and potential Alvotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alvotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 267.9 M | |
| Cash And Short Term Investments | 51.4 M |
Alvotech Fundamentals Growth
Alvotech Stock prices reflect investors' perceptions of the future prospects and financial health of Alvotech, and Alvotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alvotech Stock performance.
| Return On Asset | 0.0198 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 2.89 B | ||||
| Shares Outstanding | 311.6 M | ||||
| Price To Sales | 2.95 X | ||||
| Revenue | 489.68 M | ||||
| Gross Profit | 318.74 M | ||||
| EBITDA | (32.27 M) | ||||
| Net Income | (231.86 M) | ||||
| Cash And Equivalents | 128.44 M | ||||
| Cash Per Share | 0.52 X | ||||
| Total Debt | 1.19 B | ||||
| Current Ratio | 0.86 X | ||||
| Book Value Per Share | (0.59) X | ||||
| Cash Flow From Operations | (236.84 M) | ||||
| Earnings Per Share | 0.23 X | ||||
| Market Capitalization | 1.69 B | ||||
| Total Asset | 1.22 B | ||||
| Retained Earnings | (2.44 B) | ||||
| Working Capital | 261.62 M | ||||
About Alvotech Performance
By examining Alvotech's fundamental ratios, stakeholders can obtain critical insights into Alvotech's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Alvotech is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 289.69 | 303.52 | |
| Return On Tangible Assets | (0.22) | (0.24) | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Assets | (0.22) | (0.23) | |
| Return On Equity | 0.51 | 0.48 |
Things to note about Alvotech performance evaluation
Checking the ongoing alerts about Alvotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alvotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alvotech had very high historical volatility over the last 90 days | |
| Alvotech has a very high chance of going through financial distress in the upcoming years | |
| Alvotech currently holds 1.19 B in liabilities. Alvotech has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Alvotech's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 489.68 M. Net Loss for the year was (231.86 M) with profit before overhead, payroll, taxes, and interest of 318.74 M. | |
| Alvotech currently holds about 128.44 M in cash with (236.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52. | |
| Roughly 62.0% of the company shares are held by company insiders | |
| Latest headline from globenewswire.com: Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea 2mg |
- Analyzing Alvotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alvotech's stock is overvalued or undervalued compared to its peers.
- Examining Alvotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alvotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alvotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alvotech's stock. These opinions can provide insight into Alvotech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Will Biotechnology sector continue expanding? Could Alvotech diversify its offerings? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alvotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.58) | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Understanding Alvotech requires distinguishing between market price and book value, where the latter reflects Alvotech's accounting equity. The concept of intrinsic value—what Alvotech's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Alvotech's price substantially above or below its fundamental value.
Understanding that Alvotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alvotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Alvotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.